Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Inotiv, Inc. | tm2038337d1_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Inotiv, Inc. | tm2038337d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Inotiv, Inc. | tm2038337d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Inotiv, Inc. | tm2038337d1_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - Inotiv, Inc. | tm2038337d1_ex21-1.htm |
| EX-10.18 - EXHIBIT 10.18 - Inotiv, Inc. | tm2038337d1_ex10-18.htm |
| EX-4.4 - EXHIBIT 4.4 - Inotiv, Inc. | tm2038337d1_ex4-4.htm |
| 10-K - FORM 10-K - Inotiv, Inc. | tm2038337d1_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (No.’s 333-153734 and 333-228747) on Form S-8 of Bioanalytical Systems, Inc. of our report dated December 22, 2020 relating to the consolidated financial statements of Bioanalytical Systems, Inc., appearing in this Annual Report on Form 10-K of Bioanalytical Systems, Inc. for the year ended September 30, 2020.
| /s/ RSM US LLP | |
| Indianapolis, Indiana | |
| December 22, 2020 |